To the best of our knowledge, no previous study reported the impact of p-Ser9-GSK-3β expression on the prognosis of HCC and the relationship between the expression of p-Ser9-GSK-3β and T2DM. The gene discussed is GSK3B; the disease is hepatocellular carcinoma.